Regulatory strategies for the new drug approval of opthalmic product in USA, Europe and India: a comparative study

By:

Language: English Publication details: 2017Edition: 1Description: 164pSubject(s):

DDC classification:

Dissertation note: Venkatesh M PJSS UniversityP.Regulatory Affairs

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Collection	Call number	Status	Barcode
Dissertation/Thesis	JSS College of Pharmacy, Mysuru	JSS College of Pharmacy, Mysuru	Pharmaceutics	615.48 SAM (Browse shelf(Opens below))	Available	D10446

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	615.48 SAI Regulatory requirements for pharmaceutical product registration in China	615.48 SAI Comparison of regulatory requirements with special emphasis on bioequivalence guidance for registration of generic drug products in USA, Japan, South Africa, China & India	615.48 SAJ Analysis of regulations relating to advertisements of drugs in India, USA and UK	615.48 SAM Regulatory strategies for the new drug approval of opthalmic product in USA, Europe and India: a comparative study	615.48 SAM Handling of market complaints and recall procedures for pharmaceutical product in USA and India: a comparative study	615.48 SAN Herbal drug registration in China	615.48 SAN Comparative study of regulatory requirements for the post approval changes of generics in regulated countries	Next